Hinokitiol led to tumor spheroids shrinkage as inhibited BC stem-like cells self-renewable capacity, suppressed tumor stemness-progression via inhibiting CD44/Nanog/SOX2/Oct4 signaling pathways. This evidence concerns the gene NANOG and breast cancer.